Product Images Crexont
View Photos of Packaging, Labels & Appearance
- CD Structural Formula - crexont carbidopa and levodopa extended release ca 1
- LD Structural Formula - crexont carbidopa and levodopa extended release ca 2
- 35-140 ifc - crexont carbidopa and levodopa extended release ca 3
- 52-5-210 ifc - crexont carbidopa and levodopa extended release ca 4
- 70-280 ifc - crexont carbidopa and levodopa extended release ca 5
- 87-5-350 ifc - crexont carbidopa and levodopa extended release ca 6
Product Label Images
The following 6 images provide visual information about the product associated with Crexont NDC 64896-967 by Amneal Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
35-140 ifc - crexont carbidopa and levodopa extended release ca 3

This is a description of extended-release capsules containing carbidopa and levodopa in the amounts of 35 mg and 140 mg, respectively. The recommended dosage is specified in the prescribing information. The capsules should be stored at controlled room temperature and protected from light and moisture in a tightly closed container. It is important to keep the medication out of reach of children. These capsules are distributed by Amneal Specialty, a division of Amneal Pharmaceuticals LLC, located in Bridgewater, NJ.*
52-5-210 ifc - crexont carbidopa and levodopa extended release ca 4

This is a prescription drug information for CREXONT extended-release capsules containing 52.5 mg of carbidopa and 210 mg of levodopa. The recommended dosage should be in accordance with the prescribing information. It should be stored at temperatures between 20°C to 25°C in a closed container, protected from light and moisture. It is distributed by Amneal Specialty, a division of Amneal Pharmaceuticals LLC based in Bridgewater, NJ.*
70-280 ifc - crexont carbidopa and levodopa extended release ca 5

This text provides information about an extended-release capsule containing 70 mg of carbidopa, USP and 280 mg of levodopa, USP. It includes details about the recommended dosage, storage instructions, and the manufacturer - Amneal Specialty. The capsule is used in the treatment of certain conditions, and the prescription is required for obtaining 120 capsules.*
87-5-350 ifc - crexont carbidopa and levodopa extended release ca 6

This text is a medication label for extended-release capsules containing carbidopa and levodopa. The capsules are prescribed for specific dosages and require storage at controlled room temperature, protected from light and moisture. The medication is distributed by Amneal Specialty, a division of Amneal Pharmaceuticals LLC. The label also includes the NDC numbers and dosage information.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.